NFKB1 and neoplasm: Depending on the cell type, the IL-6/STAT3-dependent pathways, such as the JAK/STAT [13], PI3K/AKT/NF-κB [43], or p38 MAPK [44], can enhance tumor growth and refractoriness to chemotherapy [13].